Mylan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.10.18	Theravance, Mylan Report Positive New Data From Multiple Studies Of Yupelri (RTTNews)
08.10.18	Theravance Biopharma And Mylan To Present Data From Studies Of YUPELRI (RTTNews)
01.10.18	Momenta Pharma Announces Restructuring; To Reduce Investment In Biosimilars (RTTNews)
21.09.18	Mylan & Biocon: CHMP Issues Positive Opinion Recommending Approval Of Fulphila (RTTNews)
20.09.18	Mylan To Launch Biosimilar To Humira In Europe - Quick Facts (RTTNews)
17.09.18	Theravance Reports Positive Data From Phase 3 Program For YUPELRI Solution (RTTNews)
12.09.18	FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct. (RTTNews)
08.08.18	Mylan Q2 Results Miss View, Cuts 2018 Outlook; To Evaluate Alternatives (RTTNews)
08.08.18	Mylan N.V. Q2 adjusted earnings Miss Estimates (RTTNews)
30.07.18	European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1 (RTTNews)
27.07.18	Mylan, Fujifilm Kyowa Kiring Get Positive CHMP Opinion For Hulio - Quick Facts (RTTNews)
28.06.18	Mylan Joins With India's Lupin To Commercialize Enbrel (Etanercept) Biosimilar (RTTNews)
18.06.18	Mylan Launches Generic Angiomax® Injection (PR Newswire)
15.06.18	Indivior To Pursue All Legal Remedies To Protect Its SUBOXONE Film In U.S. (RTTNews)
15.06.18	FDA Okays First Generic Versions Of Suboxone Sublingual Film (RTTNews)
14.06.18	Mylan Remains Firmly Negative In Late-Day Trading (RTTNews)
11.06.18	Americares Honors Mylan with Power of Partnership Award (PR Newswire)
05.06.18	InventHelp Inventor Develops Tracking System for Packages (DPH-305) (PR Newswire)
05.06.18	FDA Approves First Neulasta Biosimilar, HQY Hits New High, TGTX Turns Heads (RTTNews)
05.06.18	FDA Okays Mylan And Biocon's Fulphila, First Biosimilar To Neulasta (RTTNews)
04.06.18	U.S. FDA Approves Mylan and Biocon's Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta® (PR Newswire)
01.06.18	Mylan and Biocon to Present New Data at the American Society of Clinical Oncology (ASCO) Annual Meeting Reinforcing the Efficacy, Safety and Immunogenicity of Ogivri™, the first biosimilar for... (PR Newswire)
01.06.18	Mylan to Present at Goldman Sachs 39th Annual Global Healthcare Conference (PR Newswire)
25.05.18	InventHelp Inventor Develops Line of Easy-To-Clean Area Rugs (SDB-1173) (PR Newswire)
09.05.18	Mylan Q1 Profit Up 31%, But Results Miss View; Reaffirms FY18 Outlook (RTTNews)
09.05.18	Mylan N.V. Q1 adjusted earnings Miss Estimates (RTTNews)
09.05.18	Mylan Reports First Quarter 2018 Results and Reaffirms 2018 Guidance (PR Newswire)
03.05.18	AKAO Slumps On FDA Panel Vote, ESPR Awaits Data In May, STAA Shines (RTTNews)
02.05.18	Mylan to Release First Quarter 2018 Financial Results on May 9, 2018 (PR Newswire)
21.04.18	Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone® at American Academy of Neurology 70th Annual Meeting (PR Newswire)
11.04.18	Investor Day Highlights Durability of Mylan's Global Platform (PR Newswire)
11.04.18	Mylan to Leverage its World-Class Scientific Platform to Develop a Novel Delivery for Meloxicam, a Non-Opioid Pain Medication (PR Newswire)
11.04.18	Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira® (adalimumab) (PR Newswire)
10.04.18	Mylan To Buy Marketing Rights To Mapi's Glatiramer Acetate Product (RTTNews)
10.04.18	Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma (PR Newswire)
10.04.18	Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma (PR Newswire)
09.04.18	Inventor Develops Transporter for Shopping Purchases (HUN-521) (PR Newswire)
06.04.18	Mylan Announces Pricing Of Private Offering Of $1.5 Bln Of Senior Note (RTTNews)
28.03.18	Mylan To Launch Triple Combo HIV Treatment In U.S. - Quick Facts (RTTNews)
28.03.18	Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S. (PR Newswire)
28.03.18	Mylan, Biocon Get EC, TGA Australia Nod For Biosimilar Insulin Glargine Semglee (RTTNews)
28.03.18	Mylan, Biocon Get Approval For Glargine Insulin In Europe, Australia (RTTNews)
28.03.18	Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee™, Biosimilar Insulin Glargine (PR Newswire)
21.03.18	Mylan to Host Investor Day on April 11, 2018, in New York City (PR Newswire)
20.03.18	Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin® Injection (PR Newswire)
06.03.18	Mylan Posting Strong Gain On Upgrade By Morgan Stanley (RTTNews)
02.03.18	Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S. (PR Newswire)
28.02.18	Mylan, Revance Announce License Agreement For Proposed Biosimilar To BOTOX (RTTNews)
28.02.18	Mylan N.V. Announces Retreat In Q4 Earnings (RTTNews)
28.02.18	Mylan Reports Full Year and Fourth Quarter 2017 Results and Provides 2018 Guidance (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Börse Zürich in Grün: So steht der SMI nachmittags
22.11.24		Freundlicher Handel: SLI klettert am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester

22.11.24

Börse Zürich in Grün: So steht der SMI nachmittags